Water

Water

SCHEMBL2652847

COC(C)(C)C.O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL10335432 1.00
Water SCHEMBL27670184 1.00 ALDH1A1 (0.89)
Ammonia Solution, Strong SCHEMBL26699157 0.95
SCHEMBL503396 0.94
SCHEMBL6223 0.94
SCHEMBL8679785 0.94 ALDH1A1 (1.00)
Hydrazine SCHEMBL18290955 0.91
Methyl Alcohol SCHEMBL15124588 0.91
SCHEMBL3662439 0.89
SCHEMBL3664027 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023246854-A1 CRYSTAL OF BORATE DERIVATIVE, METHOD FOR PREPARING SAME, AND USE THEREOF 瑞石生物医药有限公司 2023-12-28 WO claimed
WO-2024083545-A1 PROCESS FOR THE PREPARATION OF 4-CHLORO-2-(TRIFLUOROMETHYL)PHENYL GRIGNARD COMPOUND AND DERIVATIVES THEREOF BASF Agro B.V. (NL) 2024-04-25 WO disclosed
CN-111004090-B Rectification-molecular sieve membrane coupling process and device for separation of ternary aqueous cosolvent system 南京工业大学 2022-08-12 CN disclosed
CN-114082394-A Desulfurization adsorbent and preparation method and application thereof 大连佳纯气体净化技术开发有限公司 2022-02-25 CN disclosed
CN-114057658-A Polytriazole compound, preparation method and application thereof 中国科学院上海有机化学研究所 2022-02-18 CN disclosed
CN-107021916-B Preparation method of trans-3-methyl-5-benzylaminopiperidine 浙江医药股份有限公司 2020-06-12 CN disclosed
WO-2018134412-A1 ANTIMICROBIAL COMPOUNDS AND USES THEREOF BIOSYNTH AG (CH) 2018-07-26 WO disclosed
EP-3294735-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION Vertex Pharmaceuticals Inc. (US) 2018-03-21 EP disclosed
WO-2018030550-A1 HETEROCYCLIC COMPOUNDS WITH AN ROR(GAMMA)T MODULATING ACTIVITY TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-02-15 WO disclosed
EP-2841413-B1 PROCESS FOR PREPARING N-(5-CHLORO-2-ISOPROPYLBENZYL)CYCLOPROPANAMINE BAYER CROPSCIENCE AG (DE) 2017-07-26 EP disclosed
US-20020050476-A1 Chiral separation of enantiomers by high-speed countercurrent chromatography MA YING (US) 2002-05-02 US disclosed
US-6337021-B1 ADDING CHIRAL SELECTOR TO PRE-EQUILIBRATED IMMISCIBLE LIQUID PHASES, INTRODUCING RACEMIC MIXTURE INTO CENTRIFUGE COLUMN, ELUTING ENANTIOMERS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 2002-01-08 US disclosed
EP-0759934-B1 NEUROTENSIN ANTAGONIST PEPTIDES RHONE POULENC RORER SA (FR) 1999-04-14 EP disclosed
EP-0776333-A1 PEPTIDE ANTAGONIST INTERMEDIATES OF NEUROTENSIN Aventis Pharma S.A. (FR) 1997-06-04 EP disclosed
EP-0759934-A1 NEUROTENSIN ANTAGONIST PEPTIDES Aventis Pharma S.A. (FR) 1997-03-05 EP disclosed
WO-1995032217-A1 PEPTIDE ANTAGONIST INTERMEDIATES OF NEUROTENSIN RHONE-POULENC RORER S.A. (FR) 1995-11-30 WO disclosed
WO-1995032218-A1 NEUROTENSIN ANTAGONIST PEPTIDES RHONE-POULENC RORER S.A. (FR) 1995-11-30 WO disclosed
EP-0340247-B1 NEW PROCESS FOR THE ANTIPODAL SEPARATION OF BICYCLO 3.3.0]OCTANE-3,7-DION-2-CARBOXYLIC ACID ESTERS AND THEIR 7-MONOCETALS SCHERING AKTIENGESELLSCHAFT (DE) 1993-04-28 EP disclosed
EP-0340247-A1 NEW PROCESS FOR THE ANTIPODAL SEPARATION OF BICYCLO 3.3.0]OCTANE-3,7-DION-2-CARBOXYLIC ACID ESTERS AND THEIR 7-MONOCETALS. SCHERING AG (DE) 1989-11-08 EP disclosed
WO-1988007050-A1 NEW PROCESS FOR THE ANTIPODAL SEPARATION OF BICYCLO[3.3.0]OCTANE-3,7-DION-2-CARBOXYLIC ACID ESTERS AND THEIR 7-MONOCETALS SCHERING AKTIENGESELLSCHAFT (DE) 1988-09-22 WO disclosed